Medtronic launches new spine surgery robot following Mazor acquisition

operating room
The system converts standard 2D fluoroscopic projections into a 3D image and integrates Medtronic’s navigation platform with Mazor’s robotic guidance. (CC0 Creative Commons)

Medtronic’s new integrated robotic spine surgery system has begun treating its first U.S. patients, just months after last year’s acquisition of Mazor Robotics and a clearance from the FDA.

The medtech giant recently launched the Mazor X Stealth Edition, which combines Medtronic’s navigation platform with Mazor’s robotic guidance systems. The device provides three-dimensional planning tools and real-time visualization in the operating room for guided procedures.

"As part of our Surgical Synergy strategy, we believe Mazor X Stealth Edition will accelerate the advancement and adoption of robotic-assisted and navigated surgical technologies in spine," said Geoff Martha, president of Medtronic’s restorative therapies group, in a release.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The merger of robotics and navigation into a single platform may provide more predictable and reliable procedure workflows, said Jeffrey Gum, M.D., an orthopedic spine surgeon at Norton Leatherman Spine Center in Louisville, Kentucky, one of the first locations to employ the system.

RELATED: Medtronic buys remainder of Mazor Robotics in $1.6B deal

"Computerized surgical planning, 3D assessment of spine anatomy, robotic guidance and live navigation feedback are designed to provide a higher degree of accuracy throughout the surgical procedure," Gum added.

The surgical robot, which converts standard 2D fluoroscopic projections into a 3D image, was first used at Norton Healthcare as well as at Reston Hospital Center in Virginia, and Medtronic said it plans to roll out the system to different regions throughout the year.

RELATED: Medtronic enters robotic spinal surgery in a partnership with, investment in Israeli small cap

The Mazor X Stealth Edition received 510(k) clearance from the FDA in November 2018, after Medtronic acquired Mazor earlier that September in a $1.6 billion deal—the culmination of a series of investments in the Israel-based robotics company beginning in May 2016.

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Barely two years after paying up $263 million for the ex-Asia rights to BeiGene’s tislelizumab, Celgene is bowing out—to the tune of $150 million.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.